20 %Au Cameroun, en République du Congo, au Gabon, au Ghana et au Nigéria, les taux de prévalence du trait drépanocytaire varient entre 20 et 30 %.
Cameroun · Gabon · Ghana · Nigeriatrait drépanocytaireHAL · Unilimdocument de 202 observations
Palier Gold : evidences validées mécaniquement, avec leur source primaire.
3 256 evidences · page 102 / 131
20 %Au Cameroun, en République du Congo, au Gabon, au Ghana et au Nigéria, les taux de prévalence du trait drépanocytaire varient entre 20 et 30 %.
Cameroun · Gabon · Ghana · Nigeriatrait drépanocytaireHAL · Unilimdocument de 202 observations
21 patientsTwenty-one patients died during the study of severe malaria at the Centre Hospitalier Régional Amissa Bongo.
Gabonpaludismepublié 2023Malaria JournalOpenAlexdocument de 25 observationsDOI 10.1186/s12936-023-04512-7
36,5 %In Asia, 36.5% of the K13 mutations were distributed within two areas—one in Cambodia, Vietnam, and Laos and the other in western Thailand, Myanmar, and China—with no overlap.
Gabonpaludismepublié 2016The New England journal of medicineeurope_pmcdocument de 2 observations
23,3 %The mortality rate among the study population was 23.3%.
Gabonnosocomial infectionobservé December 2012 to December 2016publié 2018Neonatal and Pediatric MedicineOpenAlexdocument de 14 observations
30 %The initial parasite density was as high as 30% infected erythrocytes.
Gabonpaludismepublié 2024International journal of infectious diseases : IJID : official publication of the InternatPubMeddocument de 3 observations
3 %Blood cultures revealed septicemia in 3% of 593 febrile pediatric patients hospitalized in Lambaréné, Gabon, from August 2015 to March 2016.
Gabonsepticemiaobservé August 2015 to March 2016publié 2020Scientific reportseurope_pmcdocument de 4 observations
22 cases22 children (24%) remained anemic until Day 28 after treatment with parenteral artesunate followed by oral artemisinin-combination therapy.
Gabonsevere P. falciparum malariapublié 2019Scientific reportseurope_pmcdocument de 5 observationsDOI 10.1038/s41598-019-54639-4
51,4 %Adverse events of any cause occurred in 51.4% (18/35) of patients receiving ferroquine 400 mg alone.
Gabonpaludismepublié 2023Malaria journaleurope_pmcdocument de 13 observations
91 casesOf 143 children with severe P. falciparum malaria in Ghana and Gabon, 91 (88%) had anemia (Hb < 10 g/dL) at presentation.
Gabon · Ghanasevere P. falciparum malariapublié 2019Scientific reportseurope_pmcdocument de 5 observationsDOI 10.1038/s41598-019-54639-4
4,6 %P. ovale was detected in 42 out of 908 (4.6%) participants.
GabonpaludismeHAL · Unilimdocument de 153 observations
100 %The PCR-corrected day 28 adequate clinical and parasitological response (ACPR) rate was 100% in the fosmidomycin-piperaquine treatment group.
GabonPlasmodium falciparum monoinfectionpublié 2018Clinical infectious diseases : an official publication of the Infectious Diseases Society europe_pmcdocument de 4 observations
3,7 %For 3.7% of the population, the death of a close relative during a sickle cell crisis was the point at which they became aware of the seriousness of sickle cell disease.
GabondrépanocytoseHAL · Unilimdocument de 90 observations
46,9 %46,9 % des enfants dépistés étaient homozygotes pour la drépanocytose.
Gabondrépanocytoseobservé du 1er janvier au 30 septembre 2016publié 2020Africa SanguineOpenAlexdocument de 4 observationsDOI 10.4314/asan.v22i1.2
86 patientsAmong 305 surveyed patients with COVID-19, 86 (28%) had diabetes, which posed a risk of adverse interactions with hydroxychloroquine.
GabonCOVID-19 · diabète (non précisé)publié 2021International journal of infectious diseases : IJID : official publication of the InternatPubMeddocument de 8 observations
0 deathsThere were no deaths in the study.
Gabonpaludismepublié 2023Malaria journaleurope_pmcdocument de 13 observations
25 %In Lambaréné, Gabon, the mortality rate among TB/HIV coinfected patients was 25%.
Gabontuberculose · VIH/sidapublié 2016The American journal of tropical medicine and hygieneeurope_pmcdocument de 12 observationsDOI 10.4269/ajtmh.15-0668
97,5 %Plasmodium falciparum accounted for 97.5% of malaria cases (158/162).
Gabonpaludismepublié 2016Parasite (Paris, France)europe_pmcdocument de 9 observations
900 pg/mlUncomplicated malaria IL-12 levels were 900 ± 450 pg/ml in Gabonese children.
Gabonpaludismepublié 2017American journal of clinical and experimental immunologyeurope_pmcdocument de 9 observations
9 individualsAmong 274 participants assessed for malaria by microscopy, 9 out of 45 individuals with parasite count above 10,000/µl were adults in Lambaréné and surrounding villages in Gabon.
Gabonpaludismeobservé 2018publié 2019Malaria journaleurope_pmcdocument de 8 observationsDOI 10.1186/s12936-019-3002-9
Children co-infected with Anaplasma spp. and helminths had lower TGF-β and IL-10 levels than children co-infected with Anaplasma spp., Plasmodium spp. and helminths.
Gabonhelminths · paludismepublié 2025Parasites & vectorseurope_pmcdocument de 7 observations
800 parasites/μLLa densité médiane de Plasmodium spp. était de 800 parasites/μL chez les enfants positifs, avec un intervalle interquartile de [264–3060] parasites/μL.
GabonpaludismeHAL · Unilimdocument de 81 observations
114,7 mg/LThe mean concentration of CRP in TB patients was 114.7 mg/L at diagnosis.
Gabontuberculosepublié 2023Journal of clinical tuberculosis and other mycobacterial diseasesPubMeddocument de 5 observations
5 casesIn a subset of 37 Cell-Dyn positive but microscopy negative samples from pregnant women in Lambaréné, Gabon, PCR detected five malaria-positive cases.
Gabonpaludismepublié 2009Acta tropicaeurope_pmcdocument de 2 observations
20 %Atovaquone/proguanil treatment efficacy is 20%–26% for Plasmodium vivax malaria.
Gabonpaludismepublié 2018The Journal of antimicrobial chemotherapyPubMeddocument de 4 observations
16 %Among 274 participants assessed for malaria by microscopy, 16% had a parasite count above 10,000/µl in Lambaréné and surrounding villages in Gabon.
Gabonpaludismeobservé 2018publié 2019Malaria journaleurope_pmcdocument de 8 observationsDOI 10.1186/s12936-019-3002-9
Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.